Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

2022138 citationsJournal Articlegold Open Access

Authors

This study received funding from Reveal Genomics, IDIBAPS and the University of Padova.

Good health and well-being

Published in: EBioMedicine

Volume 75, pp. 103801-103801

Field-Weighted Citation Impact: 13.30